Department of Radiology, University of California, Davis Medical Center, 4860 Y St, Ste 3100, Sacramento, CA 95817.
Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
AJR Am J Roentgenol. 2022 Nov;219(5):804-812. doi: 10.2214/AJR.22.27901. Epub 2022 Jun 22.
Washout CT is commonly used to evaluate indeterminate adrenal nodules, although its diagnostic performance is poorly established in true adrenal incidentalomas. The purpose of this study was to compare, in patients without a known malignancy history, the prevalence of malignancy for incidental adrenal nodules with unenhanced attenuation more than 10 HU that do and do not show absolute washout of 60% or more, thereby determining the diagnostic performance of washout CT for differentiating benign from malignant incidental adrenal nodules. This retrospective six-institution study included 299 patients (mean age, 57.3 years; 180 women, 119 men) without known malignancy or suspicion for functioning adrenal tumor who underwent washout CT, which showed a total of 336 adrenal nodules with a short-axis diameter of 1 cm or more, homogeneity, and unenhanced attenuation over 10 HU. The date of the first CT ranged across institutions from November 1, 2003, to January 1, 2017. Washout was determined for all nodules. Reference standard was pathology ( = 54), imaging follow-up (≥ 1 year) ( = 269), or clinical follow-up (≥ 5 years) ( = 13). Prevalence of malignancy among all nodules, nodules less than 4 cm, and nodules 4 cm or more was 1.5% (5/336; 95% CI, 0.5-3.4%), 0.3% (1/317; 95% CI, 0.0-1.7%), and 21.1% (4/19; 95% CI, 6.1-45.6%), respectively. Prevalence of malignancy was not significantly different for nodules smaller than 4 cm with (0% [0/241]; 95% CI, 0.0-1.2%) and without (1.3% [1/76]; 95% CI, 0.0-7.1%) washout of 60% or more ( = .08) or for nodules 4 cm or larger with (16.7% [1/6]; 95% CI, 0.4-64.1%) and without (23.1% [3/13]; 95% CI, 5.0-53.8%) washout of 60% or more ( = .75). Washout of 60% or more was observed in 75.5% (243/322; 95% CI, 70.4-80.1%) of benign nodules (excluding pheochromocytomas), 20.0% (1/5; 95% CI, 0.5-71.6%) of malignant nodules, and 33.3% (3/9; 95% CI, 7.5-70.1%) of pheochromocytomas. For differentiating benign nodules from malignant nodules and pheochromocytomas, washout of 60% or more had 77.5% sensitivity, 70.0% specificity, 98.8% PPV, and 9.2% NPV among nodules smaller than 4 cm. Prevalence of malignancy is low among incidental homogeneous adrenal nodules smaller than 4 cm with unenhanced attenuation more than 10 HU and does not significantly differ between those with and without washout of 60% or more; wash-out of 60% or more has suboptimal performance for characterizing nodules as benign. Washout CT has limited utility in evaluating incidental adrenal nodules in patients without known malignancy.
冲洗 CT 通常用于评估不确定的肾上腺结节,尽管其在真正的偶然肾上腺瘤中的诊断性能尚未得到很好的确定。本研究的目的是比较在无已知恶性肿瘤病史的患者中,增强衰减值大于 10HU 的偶然肾上腺结节的恶性肿瘤发生率,这些结节是否表现出绝对洗脱率为 60%或更高,从而确定洗脱 CT 对良性和恶性偶然肾上腺结节的鉴别诊断性能。这项回顾性的六机构研究纳入了 299 名(平均年龄 57.3 岁;180 名女性,119 名男性)无已知恶性肿瘤或功能性肾上腺肿瘤怀疑的患者,他们接受了洗脱 CT 检查,共显示出 336 个短轴直径为 1 厘米或以上、均匀性和增强衰减值大于 10HU 的肾上腺结节。每个机构的首次 CT 日期从 2003 年 11 月 1 日到 2017 年 1 月 1 日不等。所有结节均进行了洗脱测定。参考标准是病理学(=54)、影像学随访(≥1 年)(=269)或临床随访(≥5 年)(=13)。所有结节、小于 4 厘米的结节和 4 厘米或更大的结节的恶性肿瘤发生率分别为 1.5%(5/336;95%CI,0.5-3.4%)、0.3%(1/317;95%CI,0.0-1.7%)和 21.1%(4/19;95%CI,6.1-45.6%)。小于 4 厘米的结节中,洗脱率为 60%或更高的(0%[0/241];95%CI,0.0-1.2%)与无洗脱率为 60%或更高的(1.3%[1/76];95%CI,0.0-7.1%)的结节(=0.08)或洗脱率为 60%或更高的(16.7%[1/6];95%CI,0.4-64.1%)与无洗脱率为 60%或更高的(23.1%[3/13];95%CI,5.0-53.8%)的结节(=0.75)之间,恶性肿瘤发生率无显著差异。在 75.5%(243/322;95%CI,70.4-80.1%)的良性结节(不包括嗜铬细胞瘤)中观察到洗脱率为 60%或更高,20.0%(1/5;95%CI,0.5-71.6%)的恶性结节和 33.3%(3/9;95%CI,7.5-70.1%)的嗜铬细胞瘤。对于将良性结节与恶性结节和嗜铬细胞瘤区分开来,洗脱率为 60%或更高时,直径小于 4 厘米的结节的敏感性为 77.5%,特异性为 70.0%,PPV 为 98.8%,NPV 为 9.2%。在增强衰减值大于 10HU 的直径小于 4 厘米的偶然、均匀性肾上腺结节中,恶性肿瘤的发生率较低,且与洗脱率为 60%或更高的结节之间无显著差异;洗脱率为 60%或更高对将结节定性为良性的表现不佳。在无已知恶性肿瘤病史的患者中,冲洗 CT 对偶然肾上腺结节的评估作用有限。